| T vs. C | nivolumab alone | Standard of Care (SoC) | nivolumab plus ipilimumab | sintilimab | atezolizumab plus bevacizumab |
| nivolumab alone | --- | NA | NA | NA | NA |
| Standard of Care (SoC) | NA | --- | NA | NA | NA |
| nivolumab plus ipilimumab | NA | NA | --- | NA | NA |
| sintilimab | NA | NA | NA | --- | NA |
| atezolizumab plus bevacizumab | NA | NA | NA | NA | --- |
pathologies: 132 - treatments: 602 result logic
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
